|
mRNA_ID
|
Gene Name
|
drug_ID
|
drug_Name
|
Disease
|
RNA_exp_pattern
|
Evidence
|
Details
|
|
ENST00000590099
|
BECN1
|
NA
|
NA
|
hepatocellular carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
NA
|
breast cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
NA
|
breast cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
NA
|
lung adenocarcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
NA
|
thyroid cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
NA
|
glioma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
NA
|
lung cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
NA
|
pancreatic cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
NA
|
osteosarcoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
NA
|
gastrointestinal stromal tumor
|
down-regulated
|
predicted
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
NA
|
lung cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
NA
|
colon cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
NA
|
hepatoblastoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
NA
|
gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
NA
|
breast cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
NA
|
breast cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
NA
|
colorectal cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000590099
|
BECN1
|
DB00244
|
Mesalazine
|
chronic ulcerative colitis
|
down-regulated
|
validated
|
more...
|
|
ENST00000590099
|
BECN1
|
DB08162
|
Fasudil
|
diabetic cardiomyopathy
|
up-regulated
|
validated
|
more...
|
|
ENST00000590099
|
BECN1
|
DB05767
|
Andrographolide
|
chondrosarcoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000590099
|
BECN1
|
DB18024
|
ICG-001
|
pediatric high-grade glioma
|
down-regulated
|
validated
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
Cyclic helix B peptide
|
renal ischemia reperfusion injury
|
up-regulated
|
validated
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
Lycium barbarum polysaccharide
|
testicular dysfunction
|
down-regulated
|
validated
|
more...
|
|
ENST00000590099
|
BECN1
|
DB12771
|
Hydroxytyrosol
|
cardiovascular disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000590099
|
BECN1
|
DB12310
|
Trehalose
|
neurodegenerative diseases
|
up-regulated
|
validated
|
more...
|
|
ENST00000590099
|
BECN1
|
DB00877
|
Sirolimus
|
catagma
|
down-regulated
|
validated
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
Tongluo Baoshen formula
|
diabetic kidney disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000590099
|
BECN1
|
DB11261
|
Atractylodes japonica root
|
alzheimer＇s disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000590099
|
BECN1
|
DB09038
|
Empagliflozin
|
parkinson＇s disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
Ethyl acetate extract of V. ciliata
|
liver injury
|
up-regulated
|
validated
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
Thiosemicarbazone
|
pancreatic cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000590099
|
BECN1
|
DB01094
|
Hesperetin
|
doxorubicin-induced testicular toxicity
|
up-regulated
|
validated
|
more...
|
|
ENST00000590099
|
BECN1
|
NA
|
Shenmai Injection
|
myocardial damage
|
down-regulated
|
validated
|
more...
|
|
ENST00000590099
|
BECN1
|
DB16101
|
Baicalein
|
osteoarthritis
|
up-regulated
|
validated
|
more...
|
|
ENST00000590099
|
BECN1
|
DB12310
|
Trehalose
|
neurodegenerative diseases
|
up-regulated
|
validated
|
more...
|